746 related articles for article (PubMed ID: 29388060)
1. How Is Rectal Cancer Managed: a Survey Exploring Current Practice Patterns in Canada.
Crawford A; Firtell J; Caycedo-Marulanda A
J Gastrointest Cancer; 2019 Jun; 50(2):260-268. PubMed ID: 29388060
[TBL] [Abstract][Full Text] [Related]
2. ["Watch and wait" strategy after neoadjuvant therapy for rectal cancer: status survey of perceptions, attitudes and treatment selection in Chinese surgeons].
Sun TT; Wang L; Yao YF; Peng YF; Zhao J; Zhan TC; Leng JH; Wang HY; Chen N; Chen PJ; Li YJ; Zhang X; Liu XZ; Zhang Y; Wu AW
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Jun; 22(6):550-559. PubMed ID: 31238634
[No Abstract] [Full Text] [Related]
3. Factors affecting management decisions in rectal cancer in clinical practice: results from a national survey.
Habr-Gama A; Perez RO; São Julião GP; Proscurshim I; Nahas SC; Gama-Rodrigues J
Tech Coloproctol; 2011 Mar; 15(1):45-51. PubMed ID: 21057971
[TBL] [Abstract][Full Text] [Related]
4. Impact of Organ-Preserving Strategies on Anorectal Function in Patients with Distal Rectal Cancer Following Neoadjuvant Chemoradiation.
Habr-Gama A; Lynn PB; Jorge JM; São Julião GP; Proscurshim I; Gama-Rodrigues J; Fernandez LM; Perez RO
Dis Colon Rectum; 2016 Apr; 59(4):264-9. PubMed ID: 26953984
[TBL] [Abstract][Full Text] [Related]
5. [Reassessment of practice of Chinese surgeons since introduction of the watch and wait strategy after neoadjuvant therapy for rectal cancer].
Zhao MH; Sun TT; Wang L; Huang YL; Xie XY; Lu Y; Zhao GH; Wu AW
Zhonghua Wei Chang Wai Ke Za Zhi; 2024 Apr; 27(4):383-394. PubMed ID: 38644244
[No Abstract] [Full Text] [Related]
6. [Analysis on efficacy and safety of total neoadjuvant therapy in patients with locally advanced rectal cancer with high risk factors].
Ouyang GL; Meng WJ; Shu P; Deng XB; Wu B; Jiang D; Zhuang H; Shen YL; Zhou ZG; Wang ZQ; Wang X
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Apr; 22(4):349-356. PubMed ID: 31054549
[No Abstract] [Full Text] [Related]
7. Transanal local excision for distal rectal cancer and incomplete response to neoadjuvant chemoradiation - does baseline staging matter?
Perez RO; Habr-Gama A; São Julião GP; Proscurshim I; Coelho AQ; Figueiredo MN; Fernandez LM; Gama-Rodrigues J
Dis Colon Rectum; 2014 Nov; 57(11):1253-9. PubMed ID: 25285691
[TBL] [Abstract][Full Text] [Related]
8. Achieving a Complete Clinical Response After Neoadjuvant Chemoradiation That Does Not Require Surgical Resection: It May Take Longer Than You Think!
Habr-Gama A; São Julião GP; Fernandez LM; Vailati BB; Andrade A; Araújo SEA; Gama-Rodrigues J; Perez RO
Dis Colon Rectum; 2019 Jul; 62(7):802-808. PubMed ID: 31188180
[TBL] [Abstract][Full Text] [Related]
9. Implementing new surgical technology: a national perspective on case volume requirement for proficiency in transanal total mesorectal excision.
Palter VN; de Montbrun SL
Can J Surg; 2020 Jan; 63(1):E21-E26. PubMed ID: 31967441
[TBL] [Abstract][Full Text] [Related]
10. [Rational evaluation of the complete response after neoadjuvant therapy in locally advanced mid-low rectal cancer: the pros and cons of "watch and wait" strategy].
Gu J
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Jun; 22(6):507-513. PubMed ID: 31238630
[TBL] [Abstract][Full Text] [Related]
11. Transanal endoscopic microsurgery for residual rectal cancer (ypT0-2) following neoadjuvant chemoradiation therapy: another word of caution.
Perez RO; Habr-Gama A; Lynn PB; São Julião GP; Bianchi R; Proscurshim I; Gama-Rodrigues J
Dis Colon Rectum; 2013 Jan; 56(1):6-13. PubMed ID: 23222274
[TBL] [Abstract][Full Text] [Related]
12. Watch and wait approach following extended neoadjuvant chemoradiation for distal rectal cancer: are we getting closer to anal cancer management?
Habr-Gama A; Sabbaga J; Gama-Rodrigues J; São Julião GP; Proscurshim I; Bailão Aguilar P; Nadalin W; Perez RO
Dis Colon Rectum; 2013 Oct; 56(10):1109-17. PubMed ID: 24022527
[TBL] [Abstract][Full Text] [Related]
13. Pathologic Complete Response in Rectal Cancer: Can We Detect It? Lessons Learned From a Proposed Randomized Trial of Watch-and-Wait Treatment of Rectal Cancer.
Nahas SC; Rizkallah Nahas CS; Sparapan Marques CF; Ribeiro U; Cotti GC; Imperiale AR; Capareli FC; Chih Chen AT; Hoff PM; Cecconello I
Dis Colon Rectum; 2016 Apr; 59(4):255-63. PubMed ID: 26953983
[TBL] [Abstract][Full Text] [Related]
14. Management of primary rectal cancer by surgeons in Atlantic Canada: results of a regional survey.
Chuah TK; Lee T; Wirtzfeld D; Pollett W
Can J Surg; 2010 Dec; 53(6):396-402. PubMed ID: 21092432
[TBL] [Abstract][Full Text] [Related]
15. Long-term Outcome of an Organ Preservation Program After Neoadjuvant Treatment for Rectal Cancer.
Martens MH; Maas M; Heijnen LA; Lambregts DM; Leijtens JW; Stassen LP; Breukink SO; Hoff C; Belgers EJ; Melenhorst J; Jansen R; Buijsen J; Hoofwijk TG; Beets-Tan RG; Beets GL
J Natl Cancer Inst; 2016 Dec; 108(12):. PubMed ID: 27509881
[TBL] [Abstract][Full Text] [Related]
16. Complete clinical response to neoadjuvant chemoradiotherapy for rectal cancer: an Australasian perspective.
Behrenbruch C; Ryan J; Lynch C; Wynn G; Heriot A
ANZ J Surg; 2015 Mar; 85(3):103-4. PubMed ID: 25732390
[No Abstract] [Full Text] [Related]
17. Transanal Total Mesorectal Excision Versus Laparoscopic Surgery for Rectal Cancer Receiving Neoadjuvant Chemoradiation: A Matched Case-Control Study.
Chen CC; Lai YL; Jiang JK; Chu CH; Huang IP; Chen WS; Cheng AY; Yang SH
Ann Surg Oncol; 2016 Apr; 23(4):1169-76. PubMed ID: 26597369
[TBL] [Abstract][Full Text] [Related]
18. Long-term outcome of local excision after preoperative chemoradiation for ypT0 rectal cancer.
Stipa F; Picchio M; Burza A; Soricelli E; Vitelli CE
Dis Colon Rectum; 2014 Nov; 57(11):1245-52. PubMed ID: 25285690
[TBL] [Abstract][Full Text] [Related]
19. A watch-and-wait approach for locally advanced rectal cancer after a clinical complete response following neoadjuvant chemoradiation: a systematic review and meta-analysis.
Dossa F; Chesney TR; Acuna SA; Baxter NN
Lancet Gastroenterol Hepatol; 2017 Jul; 2(7):501-513. PubMed ID: 28479372
[TBL] [Abstract][Full Text] [Related]
20. Surgeon-Level Variation in Utilization of Local Staging and Neoadjuvant Therapy for Stage II-III Rectal Adenocarcinoma.
Swords DS; Skarda DE; Sause WT; Gawlick U; Cannon GM; Lewis MA; Scaife CL; Gygi JA; Tae Kim H
J Gastrointest Surg; 2019 Apr; 23(4):659-669. PubMed ID: 30706375
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
